S-23
Muscle & Strength · SARM
Tier D
Bottom line
Read Off Label grades S-23 as D (2.9/10) based on very weak evidence, unclear benefit magnitude, and a unknown-high-risk safety profile.
Developed at Kaken Pharmaceutical / GTx as contraceptive.
Typical use: Typical illicit: 10-30 mg/day PO — NOT FDA-approved; gray market; banned sport.
What this is
Developed at Kaken Pharmaceutical / GTx as contraceptive. Because it fully suppresses spermatogenesis at moderate doses, 'SARM-like' billing is misleading — closer to an AAS in effect. Limited popularity due to severity of side effect profile.
Mechanism
Strong SARM with high AR binding and full agonist activity in androgenic tissues; originally developed as male hormonal contraceptive candidate
Dose & route
Typical illicit: 10-30 mg/day PO
Citations
- https://pubmed.ncbi.nlm.nih.gov/17356133/
- https://pubmed.ncbi.nlm.nih.gov/14761987/
- https://pubmed.ncbi.nlm.nih.gov/29378245/
Links go to the source. If a link is dead or you want something re-checked, let me know.
Common questions
- Does S-23 work?
- Read Off Label rates the evidence for S-23 as Very Weak and the benefit magnitude as unclear, producing an overall grade of D (2.9/10). Developed at Kaken Pharmaceutical / GTx as contraceptive.
- Is S-23 safe?
- S-23 has a unknown-high risk profile in published human data. Legal status: NOT FDA-approved; gray market; banned sport. This is not medical advice — see the disclaimer.
- What is the typical dose for S-23?
- Typical illicit: 10-30 mg/day PO
- How does S-23 work?
- Strong SARM with high AR binding and full agonist activity in androgenic tissues; originally developed as male hormonal contraceptive candidate
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.